Hundred years of allergen immunotherapy

Clinical and Experimental Allergy

Volumn 41, Issue 9, 2011, Pages 1221-1225

  Frew, A J ^a  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALLERGEN;

ALLERGIC RHINITIS; DRUG EFFICACY; DRUG SAFETY; HAY FEVER; HISTORY OF MEDICINE; HUMAN; IMMUNOTHERAPY; PRICK TEST; PRIORITY JOURNAL; REVIEW; SPECIFIC IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY;

ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; HYPERSENSITIVITY;

EID: 80051802392     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03768.x     Document Type: Review

References (44)

1. Bostock J. Case of periodical affection of the eyes and chest. Med Chir Trans 1819; 10:161-2.
2. Wyman M. Autumnal catarrh. Cambridge: Hurd & Houghton, 1872.
3. Blackley CH. Experimental researches on the causes and nature of catarrhus aestivus. London: Bailliere, Tindall & Cox, 1873.
4. Dunbar WP. The present state of our knowledge of hay-fever. J Hyg 1913; 13:105-48.
5. Meltzer SJ. Bronchial asthma as a phenomenon of anaphylaxis. JAMA 1910; 55:1021-4.
6. Besredka A, Steinhardt E. De l'anaphylaxie et de l'antianaphylaxie vis-a-vis le serum de cheval. Ann Inst Pasteur 1907; 21:117.
7. Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 1:1572-3.
8. Freeman J. Vaccination against hay fever: report of results during the first three years. Lancet 1914; 1:1178-80.
9. Clowes GHA. A preliminary communication on certain specific reactions exhibited in hay fever cases. Proc Soc Exp Biol Med 1912-1913; 10:69.
10. Koessler KK. The specific treatment of hay fever by active immunisation. Ill Med J 1914; 24:120-7.
11. Lowdermilk RC. Hay fever. JAMA 1914; 63:141-2.
12. Cooke R. The treatment of hay fever by active immunisation. Laryngoscope 1915; 25:108-12.
13. Kern RA. Dust sensitisation in bronchial asthma. Med Clin N Am 1921; 5:751-8.
14. Boatner CH, Efron BG. Studies with antigens. XII. Preparation and properties of concentrates of house dust allergen. J Invest Dermatol 1942; 5:7-10.
15. Cooke RA. Studies in hypersensitiveness IX. On the phenomenon of hyposensitisation (the clinical lessened sensitiveness of allergy). J Immunol 1922; 7:219-42.
16. Levine P, Coca A. Studies in hypersensitiveness XXII. On the nature of alleviating effect of the specific treatment of atopic conditions. J Immunol 1926; 11:449-64.
17. Jadassohn W. Beitrage zum idiosynkrasie problem. Klin Wochenschr 1926; 5:1957.
18. Anon. Report of the joint committee on standards. J Allergy 1935; 6:408.
19. Cooke RA, Barnard JH, Hebald S, Stull A. Serological evidence of immunity with coexisting sensitisation in a type of human allergy (hay fever). J Exp Med 1935; 62:733-50.
20. Cooke RA, Loveless M, Stull A. Studies on immunity in a type of human allergy (hay fever): serologic reponse of non-sensitive individuals to pollen injections. J Exp Med 1937; 66:689-96.
21. Frankland AW, Augustin R. Prophylaxis of summer hay fever and asthma: controlled trial comparing crude grass pollen extracts with isolated main protein component. Lancet 1954; 1:1055-7.
22. Lowell FC, Franklin W. A double blind study of the effectiveness and specificity of injection therapy in ragweed hay fever. N Engl J Med 1965; 273:675-9.
23. Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children. A 14 year study. Pediatrics 1968; 42:793-802.
24. Pienkowski M, Norman PS, Lichtenstein LM. Suppression of late-phase reactions by immunotherapy with ragweed extract. J Allergy Clin Immunol 1985; 76:729-34.
25. Loveless MH. Application of immunologic principles to the management of hay fever, including a preliminary report on the use of Freund's adjuvant. Am J Med Sci 1947; 214:559-67.
26. Loveless MH. Shortening the immunisation procedure in pollen allergy; experiments with 101 ragweed-sensitive subjects during 13 years. Bull N Y Acad Med 1952; 28:538.
27. Marsh DG, Lichtenstein LM, Campbell DH. Studies on "allergoids" prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinised rye group I component. Immunology 1970; 18:705-22.
28. Hedlin G, Silber G, Schieken L et al. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J. Allergy Clin Immunol 1989; 84:390-9.
29. Committee on the Safety of Medicines. CSM update: immunotherapy. Br Med J 1986; 293:948.
30. Stewart GE, Lockey RF. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol 1992; 90:567-78.
31. Bernstein DI, Wanner M, Borish L, Liss GM. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 2004; 113:1129-36.
32. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by anti-allergic drugs. Br Med J 1991; 302:265-9.
33. Frew AJ, Powell RJ, Corrigan CJ, Durham SR. Clinical efficacy and safety of specific allergy vaccination with Alutard Grass in seasonal allergic rhinoconjunctivitis: a large-scale randomised double-blind placebo-controlled multi-centre study (UKIS - The UK Immunotherapy Study). J Allergy Clin Immunol 2006; 117:319-25.
34. Durham SR, Walker SM, Varga EM et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341:468-75.
35. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007, CD001936.
36. Bousquet PJ, Calderón MA, Demoly P et al. The Consolidated Standards of Reporting Trials (CONSORT) statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article. J Allergy Clin Immunol 2011; 127:49-56.
37. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60:4-12.
38. Alvarez-Cuesta E, Berges-Gimeno P, Mancebo EG et al. Sublingual immunotherapy with a standardised cat dander extract: evaluation of efficacy in a double-blind placebo-controlled study. Allergy 2007; 62:810-7.
39. Di Rienzo V, Marcucci F, Puccinelli P et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10 year prospective study. Clin Exp Allergy 2003; 33:206-10.
40. Bufe A, Ziegler-Kirbach E, Stoeckmann E et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004; 59:498-504.
41. Frew AJ. Sublingual immunotherapy. N Engl J Med 2008; 358:2259-64.
42. Khinchi MS, Poulsen LK, Carat F, Andre C, Hansen AB, Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004; 59:45-53.
43. Mauro M, Russello M, Incorvaia C, Gazzola GB, Di Cara G, Frati F. Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study. Eur Ann Allergy Clin Immunol 2007; 39:119-22.
44. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011; 127:18-27.